Emilio Gonzalez

Emailebgonzalutmbedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research Strategic Pillar Keywords

Infectious/ Immunological Health

Fingerprint

Dive into the research topics where Emilio Gonzalez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

20 Completed

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
3/6/17 → 3/5/19
Project: Other project
Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
3/6/17 → 3/5/19
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
8/26/14 → 8/25/16
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
8/26/14 → 8/25/16
Project: Other project
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Gonzalez, E.
7/28/14 → 7/27/16
Project: Other project

1656 Citations
26 h-Index
58 Article
9 Review article
7 Letter
4 Comment/debate
More
- 1 Chapter

Non-Healing Leg Ulcers in a Patient with Rheumatoid Arthritis
Sood, A., Gonzalez, D., Sonkar, J., Murthy, V. & Gonzalez, E., Oct 2021, In: American Journal of Medicine. 134, 10, p. e522-e523
Research output: Contribution to journal › Article › peer-review
Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome
Shemer, A., Willis, R., Gonzalez, E. B., Romay-Penabad, Z., Shovman, O., Shoenfeld, Y., Blank, M. & Amital, H., May 2019, In: Journal of Autoimmunity. 99, p. 98-103 6 p.
Research output: Contribution to journal › Article › peer-review
7 Scopus citations
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Radin, M., Sciascia, S., Erkan, D., Pengo, V., Tektonidou, M. G., Ugarte, A., Meroni, P., Ji, L., Belmont, H. M., Cohen, H., Ramires de Jesús, G., Branch, D. W., Fortin, P. R., Andreoli, L., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Knight, J. S., Atsumi, T., Willis, R. & 11 others, Gonzalez, E., Lopez-Pedrera, R., Rossi Gandara, A. P., Borges Gualhardo Vendramini, M., Banzato, A., Sevim, E., Barbhaiya, M., Efthymiou, M., Mackie, I., Bertolaccini, M. L. & Andrade, D., Dec 2019, In: Seminars in Arthritis and Rheumatism. 49, 3, p. 464-468 5 p.
Research output: Contribution to journal › Article › peer-review
17 Scopus citations
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
Erkan, D., Unlu, O., Sciascia, S., Belmont, H. M., Branch, D. W., Cuadrado, M. J., Gonzalez, E., Knight, J. S., Uthman, I., Willis, R., Zhang, Z., Wahl, D., Zuily, S. & Tektonidou, M. G., Mar 1 2018, In: Lupus. 27, 3, p. 399-406 8 p.
Research output: Contribution to journal › Article › peer-review
34 Scopus citations
PEGylated Domain I of Beta-2-Glycoprotein I inhibits the binding coagulopathic, and thrombogenic properties of IgG From patients with the antiphospholipid syndrome
McDonnell, T. C. R., Willis, R., Pericleous, C., Ripoll, V. M., Giles, I. P., Isenberg, D. A., Brasier, A., Gonzalez, E. B., Papalardo, E., Romay-Penabad, Z., Jamaluddin, M., Ioannou, Y. & Rahman, A., Oct 22 2018, In: Frontiers in immunology. 9, OCT, 2413.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations

Emilio Gonzalez, MD

Personal profile

Research Strategic Pillar Keywords

Fingerprint

Network

Dive into details

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

Non-Healing Leg Ulcers in a Patient with Rheumatoid Arthritis

Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

PEGylated Domain I of Beta-2-Glycoprotein I inhibits the binding coagulopathic, and thrombogenic properties of IgG From patients with the antiphospholipid syndrome

Emilio Gonzalez, MD

Personal profile

Research Strategic Pillar Keywords

Fingerprint

Network

Projects

Research output